tiprankstipranks
Trending News
More News >
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market

Aardvark Therapeutics, Inc. (AARD) Income Statement

Compare
12 Followers

Aardvark Therapeutics, Inc. Income Statement

Last quarter (Q1 2025), Aardvark Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Aardvark Therapeutics, Inc.'s net income was $-9.31M. See Aardvark Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 22.79M$ 7.42M$ 11.36M
Depreciation and Amortization
$ 16.00K$ 97.00K$ 110.00K
EBITDA
$ -22.79M$ -7.32M$ -10.25M
Operating Income
$ -22.79M$ -7.42M$ -11.36M
Other Income/Expenses
$ 2.20M$ 207.00K$ -2.20M
Pretax Income
$ -20.59M$ -7.21M$ -13.56M
Net Income
$ -20.59M$ -7.21M$ -13.56M
Per Share Metrics
Basic EPS
$ -1.59$ -0.56$ -1.39
Diluted EPS
$ -1.59$ -0.56$ -1.39
Weighted Average Shares Outstanding
12.91M 12.91M 9.73M
Weighted Average Shares Outstanding (Diluted)
12.91M 12.91M 9.73M
Currency in USD

Aardvark Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis